Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Add To Watchlist

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Nitric Oxide News, SaNOtize

View:

Post by Red~One on Jul 13, 2022 2:10pm

Nitric Oxide News, SaNOtize

"Phase 3 trial demonstrated a reduction in SARS-CoV-2 viral load in high-risk COVID-19 patients by 94% and 99% within 24 and 48 hours of treatment, respectively " SaNOtize

https://www.businesswire.com/news/home/20220713005181/en/Newly-Published-Phase-3-Study-in-People-with-COVID-19-Shows-SaNOtize-Nitric-Oxide-Nasal-Spray-Reduced-Viral-Load-by-99-within-Two-Days
[url=https://]Newly Published Phase 3 Study in People with COVID-19 Shows SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days[/url]

130

Comment

Comment by Red~One on Jul 13, 2022 2:16pm

“As we grapple with waning vaccine efficacy, mixed results from antiviral drugs and evolving variants of concern, there is an increasing need for effective and safe COVID-19 therapies,” said study author and SaNOtize Chief Scientific Officer and Co-Founder, Chris Miller, PhD. “To our knowledge, no other outpatient antiviral therapy has led to negative PCR conversion as quickly as NONS. The study ...more

127

Comment